Ohio State Navbar

Our Team

Joshua Palmer, MD


 

 

Assistant Professor, Radiation Oncology

 


Awards

  • Society of Neuro-Oncology (SNO) 20th Annual Scientific Meeting Best Oral Poster Presentation
  • AACR/ASCO Methods in Clinical Cancer Research Workshop
  • American Society of Clinical Oncology (ASCO) 2015 Conquer Cancer Foundation Oncology Trainee Award

  • American College of Radiation Oncology 2015 Essay Award

  • Alpha Omega Alpha Post-Graduate Award Winner in Clinical Research

  • Thomas Jefferson University All-Star Award for Excellence in Clinical Care

  • First Place, Resident Clinical Trial Accrual Award

  • Finalist for Jefferson Faculty Association Resident Award for Clinical Excellence, Patient Service, Empathy and Professionalism

  • First Place, Resident Clinical Trial Accrual Award

  • Alpha Omega Alpha National Medical Honor Society

  • Academic Excellence Award, University of Minnesota

  • College of Biological Sciences Gold Medallion in Basic Science Research

  • Selected for the University Honors Program in the College of Biological Sciences

Memberships

  • American Society for Radiation Oncology (ASTRO)
  • Alpha Omega Alpha Medical Honor Society (AOA)
  • American Association for Cancer Research (AACR)
  • American Society of Clinical Oncology (ASCO)
  • Association of Residents in Radiation Oncology (ARRO)
  • American College of Radiation Oncology (ACRO)
  • Radiological Society of North America (RSNA)
  • Society for Neuro-Oncology (SNO)

Journal Reviewer

  • 2015 – 2017: Annals of Translational Medicine
  • 2014 – 2017: Translational Lung Cancer Research
  • 2014 – Present: Lung Cancer
  • 2014 – Present: Radiation Oncology

Publications

  • Williams NL, Wuthrick EJ, Kim H, Palmer JD, Garg S, Eldredge-Hindy H, Daskalakis C, Feeney KJ, Mastrangelo MJ, Kim LJ, Sato T, Kendra KL, Olencki T, Liebner DA, Farrell CJ, Evans JJ, Judy KD, Andrews DW, Dicker AP, Werner-Wasik M, Shi W. Phase I study of ipilimumab combined with whole brain radiation therapy or radiosurgery for melanoma patients with brain metastases. Int J Radiat Oncol Biol Phys. In Press, 2017 May 26. doi.org/10.1016/j.ijrobp.2017.05.028
  • Wang YA, Sun Y, Palmer JD, Solomides C, Huang LC, Shyr Y, Dicker AP, Lu B. IGFBP3 modulates lung tumorigenesis and cell growth through IGF1 signaling. Mol Cancer Res. 2017 Mar 22. Online First. doi: 10.1158/1541-7786
  • Bar-Ad V, Palmer J, Li L, Lai Y, Lu B, Myers RE, Ye Z, Axelrod R, Johnson JM, Werner-Wasik, M, Cowan SW, Evans NR, Hehn BT, Solomides CC, Wang C. Neutrophil to Lymphocyte ratio associated with prognosis of lung cancer. Clin Transl Oncol. 2016 Dec 1. Epub
  • Alexander GS, Palmer JD, Tuluc M, Lin J, Dicker AP, Bar-Ad V, Harshyne LA, Louie J, Shaw CM, Hooper DC, Lu B. Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy. J Hematol Oncol. 2016 Sep;9(1):96
  • Kim H, Dan TD, Palmer JD, Leiby BE, Lawrence Y, Dicker AP. Quality and Reporting Accuracy of Phase I Drug Radiation Clinical Trials. JAMA Oncol. 2015 Dec. Online First. doi:10.1001/jamaoncol.2015.4833
  • Williams NL, Palmer JD, Weinstein JC, Rufail ML, Sama AR, Bar-Ad V, Yeo CJ, Hurwitz MD. Hepatoid carcinoma of the pancreas: A case report and review of the literature. Case Reports in Pancreatic Cancer. Accepted 2015.
  • Yeung V, Palmer JD, Williams N, Weinstein JC, Sama A, Winter J, Bar-Ad V. Metastatic adenosquamous carcinoma of the pancreas in a patient with BRCA2 mutation: A case report. Case Reports in Pancreatic Cancer. Accepted 2015.
  • Shi W, Palmer JD, Werner-Wasik M, Andres DW, Evans JJ, Glass J, Kim L, Bar-AD V, Moshel Y, Judy K, Farrell C, Simone NL, Dicker AP, Lawrence Y. Phase I study of panobinostat and fractionated stereotactic re-irradiation therapy (FSRT) for recurrent high grade gliomas. J Neurooncol. 2016 May;127(3):535-9. doi: 10.1007/s11060-016-2059-3. Epub 2016 Jan 29.
  • Dan TD, Palmer JD. Combination Targeted Therapy: Avant-garde oncology. Ann Transl Med.
  • 2015 Jul;3(11):159. doi: 10.3978/j.issn.2305-5839.2015.06.17.
  • Zhang I, Zaorsky NG, Palmer JD, Mehra R, Lu Bo. Targeting brain metastases in EML4- ALK-positive non-small cell lung cancer. Lancet Oncology. 2015 Oct; 16(13): e510-21.
  • Gong, Y, Yu J, Yeung V, Palmer J, Yu Y, Lu B, Babinsky L, Burkhart R, Leiby B, Siow V, Lavu H, Rosato E, Winter J, Lewis N, Sama A, Mitchell E, Anne P, Hurwitz M, Yeo C, Bar- Ad V, Xiao Y. SU-E-T-131: Artificial networks applied to overall survival prediction for patients with periampullary carcinoma. Med Phys. 2015 Jun; 42(6):3361. Doi: 10.1118/1.4924492.
  • Palmer JD, Siglin J, Yamoah K, Dan T, Champ CE, Bar-Ad V, Werner-Wasik M, Evans JJ, Kim L, Glass J, Farrell C, Andrews DW, Shi W. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better. J Neurooncol. 2015 Sep; 124(2):215- 21. doi:10.1007/s11060-015-1825-y. Epub 2015 May 30.
  • Zaorsky NG, Palmer JD, Hurwitz MD, Keith SW, Dicker AP, Den RB. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation. Radiother Oncol. 2015 Jun;115(3):295-300. doi: 10.1016/j.radonc.2015.05.011. Epub 2015 May 28.
  • Cai G, Zhu J, Palmer JD, Xu Y, Hu WG, Gu WL, Cai SJ, Zhang Z. CAPIRI-IMRT: A phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy in the treatment of recurrent rectal cancer. Radiat Oncol. 2015 Feb 28;10(1):57. doi: 10.1186/s13014-015-0360-5. PMID: 25889149.
  • Li Q, Li G, Palmer JD, Zhang, Zhen. Lymph node burden as a predictive factor for selective chemoradiotherapy in patients with locally advanced gastric cancer following a D2 dissection: a retrospective study. Am J Clin Oncol. 2014 Dec 10. PMID: 25503428.
  • Bar-Ad V, Palmer JD, Hushan Y, Cognetti D, Curry J, Luginbuhl A, Tuluc M, Campling B, Axelrod R. Current management of locally advanced head and neck cancer: The combination of chemotherapy with loco-regional treatments. Semin Oncol. 2014 Dec;41(6):798-806. doi: 10.1053/j.seminoncol.2014.09.018. Epub 2014 Oct 7. Review.
  • Yamoah K, Eldredge-Hindy HB, Zaorsky NG, Palmer JD, Doyle LA, Sendecki JA, Hesney AA, Harper L, Repka M, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma. Brachytherapy. 2014 Jun 18. pii: S1538-4721(14)00525-X. doi: 10.1016/j.brachy.2014.04.003.
  • Palmer JD, Soule BP, Simone BA, Zaorsky NG, Jin L, Simone NL. MicroRNA expression altered by diet: Can food be medicinal? Ageing Res Rev. 2014 May 14. pii: S1568- 1637(14)00052-X. doi: 10.1016/j.arr.2014.04.005.
  • Palmer JD, Zaorsky N, Witek M, Lu B. Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer. J Thorac Dis. 2014 Apr:6(4):387-398.
  • Champ CE, Palmer JD, Volek, JS, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Shi W. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. J Neurooncol. 2014 Mar;117(1):125-3. doi: 10.1007/s11060-014-1362-0. Epub 2014 Jan 19.
  • Zaorsky NG, Sun Y, Wang Z, Palmer JD, Fortina PM, Solomides C, Werner-Wasik M, Dicker AP, Axelrod R, Campling B, Evans N, Cowan S, Lu B. Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab. Cancer Biol Ther 2013 Oct 1; 14(10):883-7. doi: 10.1007/s11060-014-1362-0. Epub 2014 Jan 19.
  • Palmer J. Primecuts—This week in the journals: Facts on the tip of my tongue. Clinical Correlations: The NYU Langone Online Journal of Medicine. 2011 Nov 14.
  • Palmer JD*, Satahoo-Dawes S*, Manning E and Levi J. Breast and lung metastasis from pancreatic neuroendocrine carcinoma. World J Radiol. 2011 Jan 28;3(1):32-7. doi: 10.4329/wjr.v3.i1.32

 


Abstracts and Presentations

  • Palmer JD, Mehta M, Williams NL, Dicker AP, Werner-Wasik M, Shi W. Treatment recommendations for elderly patients with newly diagnosed glioblastoma lacks worldwide consensus. Oral Presentation. Society of Neuro Oncology, San Antonio, Tx 2015.
  • Palmer JD, Bhamidipati D, Bansoon R, Skowronski J, Evans JJ, Judy K, Farrell C, Andrews DW, Glass J, Werner-Wasik M, Shi W, Kim L. Concurrent temozolomide and hypofractionated radiotherapy for recurrent high grade glioma. Poster Presentation. Society of Neuro Oncology, San Antonio, Tx 2015.
  • Palmer JD, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Bar-Ad V, Judy K, Farrell C, Simone N, Dicker AP, Shi W. Phase I, open-label, trial evaluating safety, tolerability and preliminary anti-tumor activity of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas. Poster Presentation. American Society of Radiation Oncology 2015.
  • Palmer JD, Mehta M, Williams NL, Dicker AP, Werner-Wasik M, Shi W. Treatment recommendations for elderly patients with newly diagnosed glioblastoma lacks worldwide consensus. Poster Presentation. American Society of Radiation Oncology 2015.
  • Palmer JD, Barsoom R, Shukla G, Skowronski J, Andrews D, Kim L, Glass J, Werner-Wasik M, Farrell C, Shi W. Patterns of failure following re-irradiation in patients with recurrent high- grade glioma. Poster Presentation. American Society of Radiation Oncology 2015.
  • Williams NL, Rivera AC, Hardin MT, Palmer JD, Doyle LA, Harrison AS, Peng C, Lallas CD, Trabulsi EJ, Gomella LG, Hurwitz MD, Dicker AP, Den RB. Phase I Study of High Dose Rate Brachytherapy Combined with Hypofractionated Intensity-modulated Radiotherapy for Intermediate Risk Prostate Cancer. Poster Presentation. American Society of Radiation Oncology 2015.
  • Shukla G, Palmer JD, Werner-Wasik M. Outcomes after whole brain reirradiation for brain metastases: A single institution experience. Poster Presentation. American Society of Radiation Oncology 2015.
  • Shi W, Siglin J, Palmer JD, Champ CE, Dan TD, Werner-Wasik M, Glass J, Kim L, Evans JE, Judy K, Farrell C, Andrews DW. Fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment. Poster Presentation. American Society of Radiation Oncology 2015.
  • Palmer JD, Strasser J, Hanlon A, Dzeda M, Witt R, Hockstein N, Raben A. Combination of radiotherapy and cetuximab for high-risk/very high risk cutaneous squamous cell carcinoma of the head and neck: A propensity score analysis. Poster Presentation. American Society of Clinical Oncology May 29-June 2, 2015
  • Kim H, Dan TD, Palmer JD, Lawrence Y, Dicker AP. It’s about time: The paucity of reported follow up and late toxicity in phase I drug-radiation therapy trials. Poster Presentation. AACR Think Tank. January 11-13, 2015.
  • Dan TD, Palmer JD, Mishra M. Towards precision medicine: Cataloging FDA-approved actionable mutations in The Cancer Genome Atlas. E-Poster presentation # e22198. American Society of Clinical Oncology May 29-June 2, 2015.
  • Palmer JD, Lim M, Lianjin K, Simone B, Rigoutsos I, Simone N. Molecular benefit of dietary alterations in breast cancer controlled via microRNAs 188 and 669. AACR 2015.
  • Palmer JD, Strasser J, Dzeda M, Hockstein N, Raben A. Combination of radiotherapy and cetuximab for high-risk/very high risk cutaneous squamous cell carcinoma of the head and neck: A propensity score analysis. Oral Presentation. American Radium Society May 2-5, 2015.
  • Yeung V, Gong Y, Palmer JD, Burkhart R, Leiby BE, Siow VS, Lavu H, Rosato E, Winter JM, Lewis N, Sama AR, Mitchell EP, Anne PR, Yu J, Yu Y, Lu B, Xiao Y, Hurwitz M, Yeo C, Bar-Ad  V.  Predicting  overall  survival  for  patients  with  peri-ampullary  carcinoma.  Poster. ASCO GI Symposium January 15-17, 2015.
  • Palmer JD, Siglin J, Yamoah K, Dan T, Champ CE, Kim L, Glass J, Werner-Wasik M, Andrews DW, Evans JJ, Shi W. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: Survival outcomes update. Oral Presentation. SNO 2014 Annual Meeting November 22-25.
  • Bar-Ad V, Lai Y, Lu B, Palmer JD, Myers R, Ye Z, Wang C, Axelrod R, Campling B, Werner-Wasik M, Cowan S, Evans N, Kumar R, Hehn B, Solomides C, Yang H. Prognostic value of the pre-diagnostic neutrophil-lymphocyte ratio (NLR) for the survival of patients with lung cancer. Poster. Chicago Multidisciplinary Symposium in Thoracic Oncology October 2014.
  • Palmer JD, Burkhart R, Yeung V, Siow VS, Lewis N, Sama A, Mitchell E, Rosato EL, Koniaris LG, Lavu H, Yeo CJ, Bar-Ad V, Winter JM. Modern clinical outcomes of periampullary cancer following pancreaticoduodenectomy and adjuvant chemoradiotherapy: Single institution pancreatic cancer registry. ASTRO 2014 Annual Meeting September 22-25.
  • Palmer JD, Deshmukh S, Needleman L, Yeung Y, Burkhart RA, Leiby B, Hurwitz M, Anne P, Lavu H, Winter JM, Lewis N, Sama A, Rosato EL, Yeo CJ, Bar-Ad V. Patterns of failure in periampullary cancer following pancreaticoduodenectomy and adjuvant chemoradiotherapy with implications on radiation treatment planning. Poster. ASTRO 2014 Annual Meeting September 22-25.
  • Bar-Ad V, Lai Y, Lu B, Palmer JD, Myers R, Ye Z, Wang C, Axelrod R, Campling B, Werner-Wasik M, Cowan S, Evans N, Kumar R, Hehn B, Solomides C, Yang H. Prognostic value of the pre-diagnostic neutrophil-lymphocyte ratio (NLR) for the survival of patients with lung cancer. Oral Presentation. ASTRO 2014 Annual Meeting September 22-25.
  • Palmer JD, Li J, Kenyon L, Andrews D, Kim L, Glass J, Werner-Wasik  W,  Shi  W. Differences in biomarker expression in GBM patients with early progression after surgery. Poster. WFNO/SNO 2013 Annual Meeting November 21-24.
  • Shi W, Palmer JD, Li J, Kenyon L, Glass J, Kim L, Werner-Wasik M, Andrews D. Molecular profiling of GBM patients who develop pseudoprogression after chemoradiotherapy. Poster. WFNO/SNO 2013 Annual Meeting November 21-24.
  • Palmer JD, Siglin J, Dan T, Champ CE, Werner-Wasik M, Andrews DW, Evans JJ, Shi W. Re-resection for recurrent high-grade glioma in the setting of re-irradiation. Digital Poster. ASTRO 2013 Annual Meeting September 22-25.
  • Zaorsky NG, Sun Y, Wang Z, Palmer JD, Fortina P, Solomides C, Werner-Wasik M, Dicker AP, Lu B. Panitumumab eliminates KRAS G12D mutated cells in non-small cell lung cancer: A case report emphasizing a tumor- and mutation-specific response. Digital Poster. ASTRO 2013 Annual Meeting September 22-25.